Otofonix Helix vs Resound Vivia 9 60S microRIE

The Otofonix Helix is a behind-the-ear amplification product priced at $695, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This places it in the lower tier of the amplification product category, ranking #7 of 8 devices tested. In our standardized testing, the Helix demonstrates one clear strength: excellent feedback handling, scoring a perfect 5.0/5—well above the category average. This means users can expect stable performance without whistling or squealing during normal wear and head movements. However, the Helix shows significant limitations in other areas. Speech clarity scores are low in both quiet (1.0/5) and noisy (1.0/5) environments, falling below category averages by 1.11 and 0.37 points respectively. Music streaming capability scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. Own-voice comfort is also a weakness, particularly in the tuned configuration. At this price point, consumers should be aware that several alternatives in the same range offer stronger overall performance. The Otofonix Helix may appeal to those who prioritize feedback-free operation above other factors, but those seeking better speech understanding or streaming functionality should explore other options in the amplification product category.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.